Zai Lab Ltd at Goldman Sachs Global Healthcare Conference (Virtual) Transcript
Thank you. Thank you, everyone, for joining this session at Goldman Sachs Global Healthcare Conference. This is Ziyi Chen, China heath care analyst at Goldman. So this session is for Zai Lab. So today, we are very pleased to have the Head of BD of Zai Lab, Jonathan Wang to join this session to discuss with us the most updated progress in BD and also the overall strategy of the Zai Lab. Thank you, Jonathan, for joining us.
Thank you, Ziyi. And thank you, Goldman Sachs. Yes.
Questions & Answers
Yes. We're going to start with some of the broad questions. I think in the past 6 months, we have seen major progress in the BD side. I think -- thanks to you and your teams great effort on getting all those assets in the past 6 months, we have seen 4 major deals coming in and 4 major assets
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
